Literature DB >> 12725690

Antibody-dependent enhancement of virus infection and disease.

Sol M Cancel Tirado1, Kyoung-Jin Yoon.   

Abstract

In general, virus-specific antibodies are considered antiviral and play an important role in the control of virus infections in a number of ways. However, in some instances, the presence of specific antibodies can be beneficial to the virus. This activity is known as antibody-dependent enhancement (ADE) of virus infection. The ADE of virus infection is a phenomenon in which virus-specific antibodies enhance the entry of virus, and in some cases the replication of virus, into monocytes/macrophages and granulocytic cells through interaction with Fc and/or complement receptors. This phenomenon has been reported in vitro and in vivo for viruses representing numerous families and genera of public health and veterinary importance. These viruses share some common features such as preferential replication in macrophages, ability to establish persistence, and antigenic diversity. For some viruses, ADE of infection has become a great concern to disease control by vaccination. Consequently, numerous approaches have been made to the development of vaccines with minimum or no risk for ADE. Identification of viral epitopes associated with ADE or neutralization is important for this purpose. In addition, clear understanding of the cellular events after virus entry through ADE has become crucial for developing efficient intervention. However, the mechanisms of ADE still remain to be better understood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725690     DOI: 10.1089/088282403763635465

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  114 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

Review 2.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  EV71 infection correlates with viral IgG preexisting at pharyngo-laryngeal mucosa in children.

Authors:  Jingchang Xue; Yaoming Li; Xiaoyi Xu; Jie Yu; Hu Yan; Huimin Yan
Journal:  Virol Sin       Date:  2015-03-20       Impact factor: 4.327

4.  Randomization-Based Inference within Principal Strata.

Authors:  Tracy L Nolen; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2011-06       Impact factor: 5.033

5.  News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.

Authors:  Lynne Peeples
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-30       Impact factor: 11.205

6.  Enterovirus 71 infection of monocytes with antibody-dependent enhancement.

Authors:  Shih-Min Wang; I-Chun Chen; Ling-Yao Su; Kao-Jean Huang; Huan-Yao Lei; Ching-Chuan Liu
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

7.  Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Authors:  Tae Woo Kim; Jin Hyup Lee; Chien-Fu Hung; Shiwen Peng; Richard Roden; Mei-Cheng Wang; Raphael Viscidi; Ya-Chea Tsai; Liangmei He; Pei-Jer Chen; David A K Boyd; T-C Wu
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination.

Authors:  Donald N Forthal; Erin E Gabriel; Angela Wang; Gary Landucci; Tran B Phan
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

9.  Porcine FcεRI Mediates Porcine Reproductive and Respiratory Syndrome Virus Multiplication and Regulates the Inflammatory Reaction.

Authors:  Peidian Shi; Lilin Zhang; Jiashun Wang; Dong Lu; Yi Li; Jie Ren; Menglu Shen; Lei Zhang; Jinhai Huang
Journal:  Virol Sin       Date:  2018-05-14       Impact factor: 4.327

Review 10.  The relationship of interacting immunological components in dengue pathogenesis.

Authors:  David G Nielsen
Journal:  Virol J       Date:  2009-11-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.